For the first time in history, Medicare has the power to negotiate the price it pays for some of the costliest and most-used ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

The U.S. Centers for Medicare and Medicaid Services (CMS) said on Monday that it would announce a list of 15 drugs eligible ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

In signing an executive order aimed at reducing U.S. drug prices, President Donald Trump said some prices would be cut in ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Medicare seeks public comments as the agency plans to list up to 15 additional drugs selected for the third round of pricing ...

The third cycle of the drug price negotiations will involve drugs under Medicare Part B. New prices are set to take effect in ...

President Trump’s executive order to lower drug prices through cross-agency action left pharma leaders scrambling to make ...